Biotechnology-EMEA Market Status and Trend Report 2013-2023

SKU ID : MI- 11336919

Publishing Date : 01-Apr-2018

No. of pages : 151

PRICE
3480
5980

  • Report Summary

    Biotechnology-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biotechnology industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

    Whole EMEA and Regional Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
    Main market players of Biotechnology in EMEA, with company and product introduction, position in the Biotechnology market
    Market status and development trend of Biotechnology by types and applications
    Cost and profit status of Biotechnology, and marketing status
    Market growth drivers and challenges

    The report segments the EMEA Biotechnology market as:

    EMEA Biotechnology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
    Europe
    Middle East
    Africa

    EMEA Biotechnology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
    DNA Sequencing
    Nanobiotechnology
    Tissue engineering and Regeneration
    Fermentation
    Cell Based Assay
    PCR Technology
    Chromatography Market
    Others

    EMEA Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
    Health
    Food & Agriculture
    Natural Resources & Environment
    Industrial Processing
    Bioinformatics
    Others

    EMEA Biotechnology Market: Players Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
    Johnson & Johnson Services, Inc.
    F. Hoffmann-La Roche Ltd
    Pfizer
    Merck & Co.
    Sanofi
    AstraZeneca
    Gilead
    CELGENE CORPORATION
    Biogen
    Amgen, Inc
    Abbott
    Novo Nordisk A/S
    Novartis AG
    Lonza

    In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.


    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports